This site is intended for healthcare professionals
Drug news

FDA accepts BLA application for SEG 101 for the prevention of vaso-occlusive crises in patients with sickle cell disease

Read time: 1 mins
Last updated:18th Jul 2019
Published:16th Jul 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest